Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Otolaryngology | Pulmonary/Respiratory Diseases | Immunology/Infectious Diseases
Disease Category: Allergy
Trial Information
Seasonal allergy study for 18 and older.
A randomized, two-way crossover, multicenter, consumer preference study of two oral formulations of phenylephrine hydrochloride.
Patient Inclusion Criteria: Individuals 18 and older who suffer from seasonal allergy symptoms including congestion Documented history of allergic rhinitis caused by ragweed for at least 2 years
Patient Exclusion Criteria:
- Immunotherapy for ragweed or Xolair for 2 years
- Infection within the previous 4 weeks
- Use if cortico steroids
Dana Neilson, LVN, CCRC, Study Coordinator
Allergy Asthma Research Institute
333 Londonderry Drive, Suite #110
Waco, TX 76712
Phone: 254-751-1144, option 11
Fax: 254-751-9922
EMail: dneilson@aactx.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
